Drugs / CNTO 3649
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT02224118 | Jul 2009 → Mar 2010 | type 2 diabetes mellitus | Janssen Pharmaceutical K.K. | Completed | No outcome recorded |
| Phase 1 | NCT00882726 | Feb 2009 → Apr 2010 | type 2 diabetes mellitus | Centocor, Inc. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CNTO 3649 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00882726 ↗ |
| Route | Intravenous | “as a 2-hour IV infusion” NCT00882726 ↗ |